An open randomised non comparative phase II trial of docetaxel (taxotere) in combination with ZD1839 (Iressa) and docetaxel alone as second line chemotherapy in patients with advanced or metastatic non small cell lung cancer
Study identifier:1839IL/0137
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An open randomised non comparative phase II trial of docetaxel (taxotere) in combination with ZD1839 (Iressa) and docetaxel alone as second line chemotherapy in patients with advanced or metastatic non small cell lung cancer
Medical condition
lung cancer
Phase
Phase 2
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 May 2003
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
